Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (123 ops.)
Latest filing published 17 Feb 2026 for ALNYLAM PHARMACEUTICALS, INC..
Filing timeline
BuySaleJeffrey Poulton V
Insider track record
Disclosed buys
0
Disclosed sells
123
T+90 hit rate
83%
T+90 mean return
+16.9%
Across 12 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Jeffrey Poulton V: trading record in brief
Jeffrey Poulton V is a declared insider of Alnylam Pharmaceuticals, Inc., with filings sourced from SEC (Form 4). In total, 153 filings cover trades dated from 10 October 2019 to 4 March 2026.
Sales make up the whole of the open-market record (123 sales, €7.6M). Other entries cover 25 share grants and 3 option exercises. 2026 to date brings no purchases and 40 sales.
The newest entry dates from 6 March 2026: an open-market sale of €30k, in Alnylam Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Jeffrey Poulton V
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations38 total
4,579 shares0Common StockSEC:0001735276-26-000025:0
2,242 shares@ US$310.080831.8% of flowCommon StockSEC:0001735276-26-000025:1
3,108 shares0Common StockSEC:0001735276-25-000117:0
4,644 shares0Common StockSEC:0001735276-25-000090:0
63 shares@ US$447.981.3% of flowCommon StockSEC:0001735276-25-000090:1
147 shares@ US$449.923.1% of flowCommon StockSEC:0001735276-25-000090:2
63 shares@ US$450.921.3% of flowCommon StockSEC:0001735276-25-000090:3
168 shares@ US$451.993.5% of flowCommon StockSEC:0001735276-25-000090:4
536 shares@ US$452.9611.3% of flowCommon StockSEC:0001735276-25-000090:5
886 shares@ US$454.0418.7% of flowCommon StockSEC:0001735276-25-000090:6
392 shares@ US$454.848.3% of flowCommon StockSEC:0001735276-25-000090:7
19 shares@ US$455.820.4% of flowCommon StockSEC:0001735276-25-000090:8
15,117 shares0Common StockSEC:0001735276-25-000031:0
1,908 shares0Common StockSEC:0001735276-25-000022:0
3,109 shares0Common StockSEC:0001735276-25-000011:0
217 shares@ US$252.502.8% of flowCommon StockSEC:0001735276-25-000011:1
239 shares@ US$253.373.1% of flowCommon StockSEC:0001735276-25-000011:2
160 shares@ US$254.352.1% of flowCommon StockSEC:0001735276-25-000011:3
68 shares@ US$255.560.9% of flowCommon StockSEC:0001735276-25-000011:4
78 shares@ US$256.291.0% of flowCommon StockSEC:0001735276-25-000011:5
37 shares@ US$257.510.5% of flowCommon StockSEC:0001735276-25-000011:6
47 shares@ US$258.070.6% of flowCommon StockSEC:0001735276-25-000011:7
17 shares@ US$259.720.2% of flowCommon StockSEC:0001735276-25-000011:8
30 shares@ US$260.570.4% of flowCommon StockSEC:0001735276-25-000011:9
37 shares@ US$261.450.5% of flowCommon StockSEC:0001735276-25-000011:10
25 of 38 declarations
